PMID- 21738472 OWN - NLM STAT- MEDLINE DCOM- 20111228 LR - 20211020 IS - 1553-7374 (Electronic) IS - 1553-7366 (Print) IS - 1553-7366 (Linking) VI - 7 IP - 6 DP - 2011 Jun TI - HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target. PG - e1002109 LID - 10.1371/journal.ppat.1002109 [doi] LID - e1002109 AB - Herpes simplex virus type 2 (HSV-2) increases the risk of HIV-1 infection and, although several reports describe the interaction between these two viruses, the exact mechanism for this increased susceptibility remains unclear. Dendritic cells (DCs) at the site of entry of HSV-2 and HIV-1 contribute to viral spread in the mucosa. Specialized DCs present in the gut-associated lymphoid tissues produce retinoic acid (RA), an important immunomodulator, able to influence HIV-1 replication and a key mediator of integrin alpha(4)beta(7) on lymphocytes. alpha(4)beta(7) can be engaged by HIV-1 on the cell-surface and CD4(+) T cells expressing high levels of this integrin (alpha(4)beta(7) (high)) are particularly susceptible to HIV-1 infection. Herein we provide in-vivo data in macaques showing an increased percentage of alpha(4)beta(7) (high) CD4(+) T cells in rectal mucosa, iliac lymph nodes and blood within 6 days of rectal exposure to live (n = 11), but not UV-treated (n = 8), HSV-2. We found that CD11c(+) DCs are a major target of HSV-2 infection in in-vitro exposed PBMCs. We determined that immature monocyte-derived DCs (moDCs) express aldehyde dehydrogenase ALDH1A1, an enzyme essential for RA production, which increases upon HSV-2 infection. Moreover, HSV-2-infected moDCs significantly increase alpha(4)beta(7) expression on CD4(+) T lymphocytes and HIV-1 infection in DC-T cell mixtures in a RA-dependent manner. Thus, we propose that HSV-2 modulates its microenviroment, influencing DC function, increasing RA production capability and amplifying a alpha(4)beta(7) (high)CD4(+) T cells. These factors may play a role in increasing the susceptibility to HIV-1. FAU - Martinelli, Elena AU - Martinelli E AD - Center for Biomedical Research, Population Council, New York, New York, United States of America. emartinelli@popcouncil.org FAU - Tharinger, Hugo AU - Tharinger H FAU - Frank, Ines AU - Frank I FAU - Arthos, James AU - Arthos J FAU - Piatak, Michael Jr AU - Piatak M Jr FAU - Lifson, Jeffrey D AU - Lifson JD FAU - Blanchard, James AU - Blanchard J FAU - Gettie, Agegnehu AU - Gettie A FAU - Robbiani, Melissa AU - Robbiani M LA - eng GR - P51 OD011104/OD/NIH HHS/United States GR - RR00164/RR/NCRR NIH HHS/United States GR - HHSN261200800001C/RC/CCR NIH HHS/United States GR - HHSN261200800001E/CA/NCI NIH HHS/United States GR - P51 RR000164/RR/NCRR NIH HHS/United States GR - R37 AI040877/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20110630 PL - United States TA - PLoS Pathog JT - PLoS pathogens JID - 101238921 RN - 0 (CD11c Antigen) RN - 0 (Integrins) RN - 0 (integrin alpha4beta7) RN - 5688UTC01R (Tretinoin) SB - IM MH - Animals MH - CD11c Antigen/immunology MH - CD4-Positive T-Lymphocytes/metabolism/pathology/*virology MH - Coinfection/*virology MH - Dendritic Cells/*pathology/virology MH - Disease Susceptibility/pathology MH - HIV Infections/complications/*virology MH - *HIV-1 MH - Herpes Genitalis/complications/*virology MH - *Herpesvirus 2, Human MH - Integrins/metabolism MH - Lymph Nodes MH - Macaca MH - Mucous Membrane/pathology/virology MH - Rectum MH - Tretinoin/metabolism PMC - PMC3128120 COIS- The authors have declared that no competing interests exist. EDAT- 2011/07/09 06:00 MHDA- 2011/12/29 06:00 PMCR- 2011/06/30 CRDT- 2011/07/09 06:00 PHST- 2010/11/11 00:00 [received] PHST- 2011/04/23 00:00 [accepted] PHST- 2011/07/09 06:00 [entrez] PHST- 2011/07/09 06:00 [pubmed] PHST- 2011/12/29 06:00 [medline] PHST- 2011/06/30 00:00 [pmc-release] AID - PPATHOGENS-D-10-00305 [pii] AID - 10.1371/journal.ppat.1002109 [doi] PST - ppublish SO - PLoS Pathog. 2011 Jun;7(6):e1002109. doi: 10.1371/journal.ppat.1002109. Epub 2011 Jun 30.